LIBX-A403
LIBX-A403 (Compound 21) is a highly selective acyl-CoA synthetase long-chain family member 4 (ACSL4) inhibitor (IC50=0.049 μM) . LIBX-A403 blocks ACSL4-mediated ferroptosis-promoting phospholipid remodeling. LIBX-A403 is promising for research of cancers (e.g., triple-negative breast cancer) and neurodegenerative diseases (e.g., Parkinson’s disease) [1].
Product Specifications
UNSPSC
12352005
Target
Ferroptosis
Related Pathways
Apoptosis
Field of Research
Cancer; Neurological Disease
Smiles
O=C(C1=C(C2=CC(/C=C/C(OC)=O)=CC=C2O1)NC(C)=O)C3=CC=CC=C3
Molecular Formula
C21H17NO5
Molecular Weight
363.36
References & Citations
[1]Charnelle E, et al. Discovery of Potent Acyl-CoA Synthetase Long-Chain Family Member 4 (ACSL4) Inhibitors with Antiferroptotic Properties[J]. Journal of Medicinal Chemistry, 2025.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1380450-01 0.02 mg (E-Coli)
Recombinant Zea mays Elongation factor 1-alpha (EF1A)
Ask
View Details MBS1380450-02 0.02 mg (Yeast)
Recombinant Zea mays Elongation factor 1-alpha (EF1A)
Ask
View Details 
MBS1380450-03 0.1 mg (E-Coli)
Recombinant Zea mays Elongation factor 1-alpha (EF1A)
Ask
View Details 
MBS1380450-05 0.02 mg (Baculovirus)
Recombinant Zea mays Elongation factor 1-alpha (EF1A)
Ask
View Details MBS1380450-06 0.02 mg (Mammalian-Cell)
Recombinant Zea mays Elongation factor 1-alpha (EF1A)
Ask
View Details